Last reviewed · How we verify
Giant cell arteritis in adults
Approved treatments
- Rinvoq · AbbVie Inc.
JAK inhibitor that prevents STAT phosphorylation and activation in cytokine signaling pathways.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Giant cell arteritis in adults patent landscape — cliff calendar, originator estates, attackable patents
- Giant cell arteritis in adults treatment landscape brief
- Giant cell arteritis in adults treatment updates RSS
Frequently asked questions about Giant cell arteritis in adults
What drugs treat Giant cell arteritis in adults?
Tracked treatments include Rinvoq.
What is the treatment for Giant cell arteritis in adults?
Standard treatment for Giant cell arteritis in adults includes Rinvoq. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Giant cell arteritis in adults patent cliff · Giant cell arteritis in adults CI report
- Treatment: Rinvoq · AbbVie Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing